Chinese study says Gilead’s remdesivir failed, firm says report ‘inconclusive’
Beijing: US-based Gilead Sciences’ remdesivir, a potential antiviral drug to treat COVID-19 patients and is under several trials around the world, has reportedly failed to produce desired results during a Chinese …
Chinese study says Gilead’s remdesivir failed, firm says report ‘inconclusive’ Read More